How tumors evade control by natural killer cells is ill defined. Smyth and colleagues show that natural killer cells in the tumor microenvironment can convert into type I innate lymphoid cells and intermediate type I innate lymphoid cells that favor tumor growth and metastasis.
Supplementary Fig S4 - PDF file 62K, Figure S4. Growth rates of carcinogen-induced tumors treated with anti-CD73/anti-PD-1 mAbs
PDF file - 208K, Dose-finding experiments comparing the relative sensitivity of established 4T1.2 (A) and AT-3 (B) tumors to ionizing radiation
Supplementary Figure 4 from Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors
PDF file - 29K, Supplementary Figure 7. Tumor-bearing WT mice lacking CD4+, CD8+ and/or NK cells or perforin respond successfully to vorinostat treatment.
Supplementary Figure S5. Anti-CD96 combines with anti-CTLA4 or anti-PD1 to enhance survival following challenge with experimental lung metastases.
Michele WL Teng合作论文数QIMR Berghofer Medical Research Institute180
Phillip Darcy合作论文数The Sir Peter Maccallum Department of Oncology, University of Melbourne;Peter MacCallum Cancer Centre;National Heath and Medical Research Council114
Michael Kershaw合作论文数The Sir Peter Maccallum Department of Oncology, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne113
Joseph Trapani合作论文数Harry Perkins Institute of Medical Research;Cancer Cell Death Laboratory, Peter Maccallum Cancer Centre;Victorian Comprehensive Cancer Centre;Department of Microbiology and Immunology, University of Melbourne109
Kazuyoshi Takeda合作论文数81
Ricky Johnstone合作论文数Gene Regulation Laboratory, Peter Maccallum Cancer Centre, The University of Melbourne;Division Medicine, Dentistry and Health Sciences, The University of Melbourne;The Sir Peter MacCallum Department of Oncology, The University of Melbourne76
Dale Godfrey合作论文数Department of Microbiology and Immunology, School of Biomedical Sciences, University of Melbourne;Peter Doherty Institute for Infection and Immunity, University of Melbourne71Ngiow Shin Foong合作论文数Trescowthick Labs, Peter MacCallum Canc Ctr70
Geoffrey Hill合作论文数Translational Science and Therapeutics Division, Fred Hutch Cancer Center;Clinical Research Division, Fred Hutch Cancer Center;Division of Hematology and Oncology, School of Medicine, University of Washington56Hideo Yagita合作论文数Department of Immunology, School of Medicine, Juntendo University54Helene Duret合作论文数53Nicole M. Haynes合作论文数50
John Stagg合作论文数Institut du Cancer de Montréal;Surface Oncology Inc.;Centre Hospitalier de l'Université de Montréal;Département de Microbiologie, Infectiologie et Immunologie, Faculté de Pharmacie, Université de Montréa46Jennifer A. Westwood合作论文数45
Yoshihiro Hayakawa (早川芳弘)合作论文数Division of Bioscience, Department of Research and Development, Institute of Natural Medicine, University of Toyama44
Laurence Zitvogel合作论文数Tumour immunology and immunotherapy, Gustave Roussy;Université Paris-Saclay43
Bald Tobias合作论文数Laboratory of Experimental Dermatology, University of Bonn43Daniel M Andrews合作论文数41Kimberley A Stannard合作论文数41
Melvyn T. Chow合作论文数Cancer Immunology Program, Peter MacCallum Cancer Centre;Sir Peter MacCallum Department of Oncology, The University of Melbourne;Peter MacCallum Cancer Centre, The University of Melbourne40
Ludovic Martinet合作论文数INSERM U1037 team 13,, Centre de Recherche en Cancérologie de Toulouse39von Scheidt Bianca合作论文数39
Michelle Yong合作论文数39
Deepak Mittal合作论文数Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute;Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute37
Mariapia Degli-Esposti合作论文数Degli-Esposti Laboratory, Monash Biomedicine Discovery Institute, Monash University;Lions Eye Institute36
Arabella Young合作论文数35Stephen Blake合作论文数35
Stephen R Mattarollo合作论文数33Stacey Allen合作论文数32Kyohei Nakamura合作论文数Department of Rheumatology, Osaki Citizen Hospital31Nicole McLaughlin合作论文数30
Alison West合作论文数30
Möller Andreas合作论文数QIMR Berghofer Medical Research Institute30
Nicholas Huntington合作论文数Neuroimmunology Laboratory;Department of Biochemistry;La Trobe University;Neuroimmunology Laboratory, La Trobe University30
Sherene Loi合作论文数Translational Breast Cancer Genomics and Therapeutics Lab, Peter MacCallum Cancer Centre29Amelia Roman Aguilera合作论文数28
Guillerey Camille合作论文数Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute28
Paul Neeson合作论文数Peter MacCallum Cancer Centre28William C. Dougall合作论文数27
Daniel Pellicci合作论文数27
Xian-Yang Li合作论文数26
Christian Engwerda合作论文数Australian Infectious Diseases Research Centre, Faculty of Science, The University of Queensland26Jennifer E. Towne合作论文数25Kuns Rachel D合作论文数25
Guido Kroemer (吉多·科罗默)合作论文数Faculty of Medicine, University of Paris Cité25
Stuart P Berzins合作论文数Department of Microbiology and Immunology, University of Melbourne25Janelle Sharkey合作论文数24
Stephen Nutt合作论文数Gene Regulation Lab, Walter and Eliza Hall Institute of Medical Research;University of Melbourne24
Gabrielle Belz合作论文数Frazer Institute, Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland;Walter and Eliza Hall Institute of Medical Research23
